Pharmcokinetics Allie punke.

Slides:



Advertisements
Similar presentations
HLTH 340 Lecture A4 Toxicokinetic processes: Distribution (part-1)
Advertisements

Dosage Regimen Design in Patients with Renal Insufficiency Cont’d Pharmacy 732 Winter, 2001.
Pharmacotherapy in the Elderly Judy Wong
Pharmacokinetics Based on the hypothesis that the action of a drug requires presence of a certain concentration in the fluid bathing the target tissue.
Dose Adjustment in Renal and Hepatic Disease
Pharmacokinetics: Asmah Nasser, M.D..
Pharmacology Department
Excretion of Drugs By the end of this lecture, students should be able to Identify main and minor routes of Excretion including renal elimination and biliary.
Prof. Hanan Hagar Pharmacology Department. What student should know  Major body fluid compartments  Concept of compartments.  Apparent volume of distribution.
CLEARANCE (CL) describes the efficiency of irreversible elimination of a drug from the body by excretion of unchanged drug. Metabolic conversion of the.
Prof. Hanan Hagar Pharmacology Department.  Is the fraction of unchanged drug that enters systemic circulation after administration and becomes available.
Pharmacokinetics Introduction
PLASMA HALF LIFE ( t 1/2 ).  Minimum Effective Concentration (MEC): The plasma drug concentration below which a patient’s response is too small for clinical.
PHARMACOKINETICS CH. 4 Part 2. GETTING IN ABSORPTION Definition – the movement of a drug from the site of administration into the fluids of the body.
1 Pharmacology Pharmacokinetics –Absorption –Distribution –Biotransformation (metabolism) –Excretion Pharmacodynamics –Receptor binding –Signal transduction.
SEIZURES IN PREGNANCY. Incidence Seizures complicate 1% of pregnancies.
PHARMACOKINETICS Part 3.
Special Populations: Pediatrics Arthur G. Roberts.
Pharmacology Department
Plasma Protein Binding
Pharmacology Department
TDM Therapeutic Drug Monitoring
Foundation Knowledge and Skills
Pharmacokinetics: Digoxin Allie Punke
DOSAGE ADJUSTMENT IN RENAL AND HEPATIC DISEASES Course Title : Biopharmaceutics and Pharmacokinetics – II Course Teacher : Zara Sheikh.
Pharmacokinetics: Warfarin
ALLIE PUNKE PHARMCOKINETICS. PHENYTOIN THE BASICS What is the volume of distribution: Regular floor patient: L/kg Critically ill patient: 0.8.
Allie punke Pharmacokinetics tutoring Fall 2016
Pharmacokienetic Principles (2): Distribution of Drugs
Basic Principles: PK By: Alaina Darby.
Drug therapy in pediatric
Kinetics Tutoring Allie Punke.
Excretion of drugs.
Allie punke Pharmacokinetics tutoring Fall 2016
Allie punke pharmcokinetics Allie punke
Pharmacokinetics: Pediatrics
Allie punke Pharmacokinetics tutoring Fall 2016
Drug Therapy in Geriatric Patients
Pharmacokinetics.
PHARMACOKINETICS Allie punke
Pharmacokinetics.
Pharmacokinetics: Warfarin
Dosing Regimen Concepts: 2-C, MM, Individualization principles
Pharmacokinetics.
Anticonvulsants: Valproic acid
Pharmacokinetics: Pediatrics
Pharmacokinetics.
Pharmacokinetics: Drug Distribution and Drug Reservoirs
Pharmacokinetics: Theophylline
به نام خدا فارماکوکینتیک نیمسال دوم دکتر ساسان زائری
Pharmacokinetics: immunosuppressive drugs
Factors affecting Drug Activity
Pharmacokinetics & Drug Dosing
Pharmcokinetics Allie punke.
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Pharmacokinetics: Drug Distribution and Drug Reservoirs
Clinical Pharmacokinetics
Pharmcokinetics Allie punke.
Allie Punke Pharmacokinetics Allie Punke
Pharmacokinetics Chapter 4
Foundations and Principles of Pharmacology
Hawler Medical University
Basic Biopharmaceutics
SIVANAGESWARARAO MEKALA
Therapeutic Drug Monitoring chapter 1 part 1
Foundations and Principles of Pharmacology
Clinical Pharmacokinetics
Clinical Pharmacokinetics
Note.
Medication Administration for Pediatrics
Presentation transcript:

pharmcokinetics Allie punke

Critical care absorption

absorption Passive diffusion OR Carrier-mediated absorption is affected in critically ill patients? What is the preferred route to feed a critically ill patient? Why? What class of drugs may further decrease gut blood flow (and therefore absorption)? If given medication for stress ulcer prophylaxis, how can this affect absorption? Vasoactive drugs…also, in shock, your body will shunt blood to heart, brain, and lungs.

absorption AB was admitted to the ICU. She is being started on enteral nutrition. What (if any) modifications should be made avoid an interaction with phenytoin? A. Nothing. It does not interact with phenytoin. B. Stop the feedings for about 30 minutes when giving phenytoin to prevent a high concentration C. Stop the feedings for about 2 hours when giving phenytoin D. The phenytoin dose should be increased to counteract any absorption problems. C

absorption When a patient is receiving enteral nutrition, there are a few medications that interact with the feedings. Phenytoin Effect: Dec. serum levels What to do: Hold tube feedings ~2 hours around dose Warfarin Effect: Decreased INR What to do: Hold tube feedings or increase dose (more so if expecting to be on feedings for long term) +/- Fluroquinolones Effect: Maybe decreased levels…maybe not clinically significant. Also, can depend on site of infection (UTI vs bacteremia)

Volume of distribution Critical care Volume of distribution

Volume of distribution What are some factors that can change Vd in ICU patients? Giving large volume of fluids pH changes Protein binding Albumin is…. Increased Or decreased in patients? AAG is….Increased Or decreased in patients? 25% of it stays intravascularly, 75% interstital. Drug may follow the fluid.

Volume of distribution MB is admitted to the ICU. Her pH is 7.18. Which of the following types of drugs would have an increased volume of distribution? A. Acidic drugs B. Basic drugs C. Neither D. Both A

Volume of distribution AB is admitted to the ICU and needs to be started on an aminoglycoside. Based on other critically ill patients, AB will also likely require: A. Higher loading dose B. Lower loading dose C. Loading dose will not change A, B Follow up: Why did we give AB a higher LD? A. Increased excretion of the drug B. Increased volume of distribution C. Both D. Neither

Volume of distribution Remember… Volume of distribution is used to calculate LD Clearance is used to calculate MD Be able to take these principles and apply to a patient’s dosing regimen

Critical care metabolism

metabolism Be able to recognize which drugs are low E vs high E (as well as the equations). Be able to recognize which drugs are bound to albumin vs AAG

metabolism AB is a patient in the ICU. Her albumin level recently fell to 1.9 from 4. Do any of her drugs need to be adjusted? A. Phenytoin dose needs to be lowered. B. Phenytoin and morphine doses need to be lowered. C. Ceftriaxone dose needs to be lowered. D. Morphine dose needs to be lowered. D (high E drug) Css,u changes.

metabolism

metabolism AB is started on propofol for sedation. Her albumin level is still low around 2.4. Should the propofol dose be adjusted? A. Yes, the Css and Css,u are both affected. B. No, neither the Css or Css,u are affected. C. Yes, because the Css is affected. D. Yes, because the Css,u is affected. D

Critical care excretion

excretion Renal function…. Decreased GFR Difficult to determine Acute kidney injury possibly may receive CRRT Fluctuating status of renal excretion

Questions? apunke@uthsc.edu